Del Monte Pacific (D03) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Oct, 2026Executive summary
DMFHL filed for Chapter 11; U.S. operations were classified as discontinued and deconsolidated effective 1 May 2025.
A US$703.5 million impairment fully wrote down U.S. assets; deconsolidation reduced total liabilities by US$1.5 billion.
Continuing Operations returned to FY2025 profitability, with focus shifting to Asian and international markets, led by DMPI.
Financial highlights
Continuing Operations FY2025 sales rose 11.1% to US$789.5 million; EBITDA increased 36% to US$140.3 million and net profit was US$10.9 million versus a US$24.9 million loss in FY2024.
4Q FY2025 sales rose 5.4% to US$191.9 million; net profit was US$5.7 million versus a US$7.0 million loss a year earlier.
FY2025 gross profit rose 30.1% to US$224.0 million; full-year gross margin reached 28.4% from 24.2%.
FY2025 operating cash flow increased to US$346.5 million from US$153.8 million.
Discontinued Operations recorded a FY2025 net loss of US$892.4 million; 4Q sales fell 12% to US$364.8 million and quarterly net loss was US$787.8 million.
Outlook and guidance
FY2026 profitability from Continuing Operations expected, barring unforeseen circumstances, primarily driven by DMPI.
Priorities include reinforcing Philippine market leadership, expanding products and channels, and maintaining leadership in North Asian fresh pineapples.
Target productivity improvement of over 15% for C74 pineapple versus FY2025; cost priorities include waste reduction and avoiding inventory write-offs.
Equity raising is a priority to address the capital deficit following U.S. impairments.
Latest events from Del Monte Pacific
- Net profit surged 192.6% on 9% higher sales, with restructuring underway to address negative equity.D03
Q1 2027 - Strong FY2026 growth and profitability, but negative equity restricts dividends.D03
Q4 2026 - Strong sales and margin gains offset U.S. exit, but negative equity and capital deficit persist.D03
Q3 2026 - Q2 sales rose 9.9% and net profit more than sevenfold, led by Asian markets and fresh exports.D03
Q2 2026 - Sales and margins rose, net profit reached US$5.5M; FY2026 profitability is expected.D03
Q1 2026 - Sales up 4% but net loss widened to US$56m on higher costs and U.S. subsidiary challenges.D03
Q2 2025 - Sales up 4% year-over-year; net loss widened on US costs, but margin and turnaround efforts continue.D03
Q1 2025 - Net loss widened to $127m on flat sales; margin recovery and asset sales targeted in FY25.D03
Q4 2024 - Sales rose, but DMFC losses outweighed DMPI growth and widened the group loss.D03
Q3 2025